Sirolimus approved with renal transplant indication.
Miller
J L
JL
D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D020123:Sirolimus / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D007166:Immunosuppressive Agents; D020123:Sirolimus